|
KMID : 1140320180020020071
|
|
Precision and Future Medicine
2018 Volume.2 No. 2 p.71 ~ p.75
|
|
|
FGFR3-TACC3: A novel gene fusion in malignant melanoma
|
|
Lee Ji-Yun
Lee Jee-Yun
Hong Sang-Duk
Jang Kee-Taek
Lee Su-Jin
|
|
|
Abstract
|
|
|
|
Oncogenic gene fusions have been identified in many cancers, and many serve as druggable targets for therapy. Fibroblast growth factor receptor (FGFR) gene aberration is known to be associated with tumor progression and resistance to anticancer therapy. Here we report the first case of malignant melanoma harboring a FGFR3-TACC3 (transforming acidic coiled-coil containing protein 3) fusion, which appears to be a promising potential therapeutic target.
|
|
|
KEYWORD
|
|
|
FGFR3-TACC3, Malignant melanoma, Novel fusion
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|